Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist–Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Yung-Chi Cheng, William H. Prusoff · Biochemical Pharmacology · 1973 · 12.9K citations

Life Sciences, Biochemistry, Chemical Kinetics +14

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

Pierre Sokoloff, Bruno Giros, Marie‐Pascale Martres et al. · Nature · 1990 · 2.6K citations · Full text

Life Sciences, Neuroscience, Pharmacology +12

Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology

Sean M Renock, Elaine G. Arrington, Louis A. Chiodo et al. · Neuropsychopharmacology · 2003 · 974 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

Kevin D. Burris, Thaddeus F. Molski, Cen Xu et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 922 citations

Medicine, Medicinal Chemistry, Pharmacology +16

H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs

Wesley K. Kroeze, Sandra J. Hufeisen, Beth A Popadak et al. · Neuropsychopharmacology · 2003 · 796 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14